Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Capricor Therapeutics (CAPR) Debt Ratio (2016 - 2024)

Capricor Therapeutics has reported Debt Ratio over the past 14 years, most recently at 0.04 for Q3 2024.

  • Quarterly results put Debt Ratio at 0.04 for Q3 2024, down 60.03% from a year ago — trailing twelve months through Sep 2024 was 0.04 (down 60.03% YoY), and the annual figure for FY2023 was 0.06, down 16.91%.
  • Debt Ratio for Q3 2024 was 0.04 at Capricor Therapeutics, down from 0.09 in the prior quarter.
  • Over the last five years, Debt Ratio for CAPR hit a ceiling of 0.24 in Q1 2020 and a floor of 0.0 in Q1 2021.
  • Median Debt Ratio over the past 5 years was 0.07 (2024), compared with a mean of 0.07.
  • Biggest five-year swings in Debt Ratio: crashed 99.66% in 2021 and later skyrocketed 7371.55% in 2022.
  • Capricor Therapeutics' Debt Ratio stood at 0.1 in 2020, then dropped by 1.37% to 0.1 in 2021, then decreased by 28.08% to 0.07 in 2022, then decreased by 16.91% to 0.06 in 2023, then plummeted by 36.81% to 0.04 in 2024.
  • The last three reported values for Debt Ratio were 0.04 (Q3 2024), 0.09 (Q2 2024), and 0.07 (Q1 2024) per Business Quant data.